Furthermore, blocking CD200–CD200R interaction exaggerates microglial activation with elevated TNF-α and IL-6 production in a 6-hydroxydopamine-induced rat model of PD, eventually causing more extensive dopaminergic neuron loss (Zhang et al., 2011). The gene discussed is CD200; the disease is Parkinson disease.